AMANDA PETER: Open Payments
NPI 1295459808 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 70 payments from 10 companies in 2025. Trend: 2023 $292 · 2024 $579 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $323 |
| Neurocrine BioSciences, Inc. | 17 | $295 |
| Alkermes, Inc. | 9 | $210 |
| Vanda Pharmaceuticals Inc. | 5 | $209 |
| E.R. Squibb & Sons, L.L.C. | 8 | $189 |
| Axsome Therapeutics, Inc. | 3 | $184 |
| Teva Pharmaceuticals USA, Inc. | 9 | $161 |
| ABBVIE INC. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
Products named: INGREZZA, ARISTADA, FANAPT, REXULTI, COBENFY, Auvelity, UZEDY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
